Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague

Christine G. Branger, Roy Curtiss, Robert D. Perry, Jacqueline D. Fetherston

Research output: Chapter in Book/Report/Conference proceedingConference contribution

26 Citations (Scopus)

Abstract

The use of live recombinant Salmonella attenuated vaccine (RASV) encoding Yersinia proteins is a promising new approach for the vaccination against Yersinia pestis. We have tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. To remove the immunosuppressive properties of LcrV protein, the lcrV gene, without the TLR2 receptor sequence, was cloned into a β-lactamase secretion vector. Immunizations were performed with RSAV expressing LcrV or Psn. Challenge with a virulent Y. pestis strain was performed 4 weeks after the last immunization. Our results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system. This finding should facilitate the design and development of a new generation of vaccines against Y. pestis.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York
Pages387-399
Number of pages13
Volume603
ISBN (Print)9780387721231
DOIs
StatePublished - 2007

Publication series

NameAdvances in Experimental Medicine and Biology
Volume603
ISSN (Print)00652598

Fingerprint

Yersinia pestis
Salmonella
Plague
Salmonella typhimurium
Vaccination
Immunization
Antigens
Attenuated Vaccines
Salmonella Vaccines
Synthetic Vaccines
Proteins
Toll-Like Receptor 2
Immunosuppressive Agents
Yersinia
Recombinant Proteins
Vaccines
Genes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Branger, C. G., Curtiss, R., Perry, R. D., & Fetherston, J. D. (2007). Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. In Advances in Experimental Medicine and Biology (Vol. 603, pp. 387-399). (Advances in Experimental Medicine and Biology; Vol. 603). Springer New York. https://doi.org/10.1007/978-0-387-72124-8_36

Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. / Branger, Christine G.; Curtiss, Roy; Perry, Robert D.; Fetherston, Jacqueline D.

Advances in Experimental Medicine and Biology. Vol. 603 Springer New York, 2007. p. 387-399 (Advances in Experimental Medicine and Biology; Vol. 603).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Branger, CG, Curtiss, R, Perry, RD & Fetherston, JD 2007, Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. in Advances in Experimental Medicine and Biology. vol. 603, Advances in Experimental Medicine and Biology, vol. 603, Springer New York, pp. 387-399. https://doi.org/10.1007/978-0-387-72124-8_36
Branger CG, Curtiss R, Perry RD, Fetherston JD. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. In Advances in Experimental Medicine and Biology. Vol. 603. Springer New York. 2007. p. 387-399. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-0-387-72124-8_36
Branger, Christine G. ; Curtiss, Roy ; Perry, Robert D. ; Fetherston, Jacqueline D. / Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Advances in Experimental Medicine and Biology. Vol. 603 Springer New York, 2007. pp. 387-399 (Advances in Experimental Medicine and Biology).
@inproceedings{f51bef818610409ca1774672495f27c2,
title = "Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague",
abstract = "The use of live recombinant Salmonella attenuated vaccine (RASV) encoding Yersinia proteins is a promising new approach for the vaccination against Yersinia pestis. We have tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. To remove the immunosuppressive properties of LcrV protein, the lcrV gene, without the TLR2 receptor sequence, was cloned into a β-lactamase secretion vector. Immunizations were performed with RSAV expressing LcrV or Psn. Challenge with a virulent Y. pestis strain was performed 4 weeks after the last immunization. Our results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system. This finding should facilitate the design and development of a new generation of vaccines against Y. pestis.",
author = "Branger, {Christine G.} and Roy Curtiss and Perry, {Robert D.} and Fetherston, {Jacqueline D.}",
year = "2007",
doi = "10.1007/978-0-387-72124-8_36",
language = "English (US)",
isbn = "9780387721231",
volume = "603",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York",
pages = "387--399",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - GEN

T1 - Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague

AU - Branger, Christine G.

AU - Curtiss, Roy

AU - Perry, Robert D.

AU - Fetherston, Jacqueline D.

PY - 2007

Y1 - 2007

N2 - The use of live recombinant Salmonella attenuated vaccine (RASV) encoding Yersinia proteins is a promising new approach for the vaccination against Yersinia pestis. We have tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. To remove the immunosuppressive properties of LcrV protein, the lcrV gene, without the TLR2 receptor sequence, was cloned into a β-lactamase secretion vector. Immunizations were performed with RSAV expressing LcrV or Psn. Challenge with a virulent Y. pestis strain was performed 4 weeks after the last immunization. Our results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system. This finding should facilitate the design and development of a new generation of vaccines against Y. pestis.

AB - The use of live recombinant Salmonella attenuated vaccine (RASV) encoding Yersinia proteins is a promising new approach for the vaccination against Yersinia pestis. We have tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. To remove the immunosuppressive properties of LcrV protein, the lcrV gene, without the TLR2 receptor sequence, was cloned into a β-lactamase secretion vector. Immunizations were performed with RSAV expressing LcrV or Psn. Challenge with a virulent Y. pestis strain was performed 4 weeks after the last immunization. Our results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system. This finding should facilitate the design and development of a new generation of vaccines against Y. pestis.

UR - http://www.scopus.com/inward/record.url?scp=84934441945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934441945&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-72124-8_36

DO - 10.1007/978-0-387-72124-8_36

M3 - Conference contribution

SN - 9780387721231

VL - 603

T3 - Advances in Experimental Medicine and Biology

SP - 387

EP - 399

BT - Advances in Experimental Medicine and Biology

PB - Springer New York

ER -